Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for TOPIRAMATE EXTENDED-RELEASE CAPSULES. TOPIRAMATE extended-release capsules, for oral useInitial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
Topiramate extended-release capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older [see Clinical Studies (14.2)]. Topiramate extended-release capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome in patients 6 years of age and older [see Clinical Studies (14.3)]. Topiramate extended-release capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older [see Clinical Studies (14.4)].
- generic_name
- topiramate
- product_names
- Topiramate
- ndc
- 68382-863, 68382-864, 68382-769, 68382-358, 68382-863-05, 68382-863-01, 68382-863-16, 68382-863-06, 68382-863-30, 68382-863-78, 68382-864-06, 68382-864-16, 68382-864-01, 68382-864-05, 68382-864-30, 68382-864-78, 68382-769-06, 68382-769-16, 68382-769-01, 68382-769-05, 68382-769-30, 68382-769-78, 68382-358-06, 68382-358-01, 68382-358-05, 68382-358-30, 68382-358-78
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en